Loading…

GORD: Investigating and managing an increasingly prevalent condition

[...]patients aged 50 years or older or those with alarm symptoms or red flags including unintentional weight loss, anaemia/signs of GI bleeding, dysphagia, odynophagia, family history in first-degree relative of upper GI malignancy, persistent vomiting, and abnormal imaging suggestive of organic di...

Full description

Saved in:
Bibliographic Details
Published in:Irish Medical Times 2019-11, p.4-6
Main Authors: O'Connell, Jim, Farrell, Richard
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 6
container_issue
container_start_page 4
container_title Irish Medical Times
container_volume
creator O'Connell, Jim
Farrell, Richard
description [...]patients aged 50 years or older or those with alarm symptoms or red flags including unintentional weight loss, anaemia/signs of GI bleeding, dysphagia, odynophagia, family history in first-degree relative of upper GI malignancy, persistent vomiting, and abnormal imaging suggestive of organic disease should be referred for an urgent endoscopy. [...]it often presents with dyspeptic symptoms. In patients with dyspepsia or GORD who have had H. pylori ruled out and are non-responsive to lifestyle modification, it is reasonable to start a trial of acid suppression therapy - a four-week treatment period with high-dose PPI therapy followed by a stepdown to the lowest dose that keeps symptoms under control. Some patients whose symptoms persist despite an adequate trial of high-dose PPI therapy may benefit from the addition of antacids like Gaviscon, fast-acting histamine antagonists like famotidine and prokinetic agents like Motilium to increase oesopha-geal peristalsis and gastric clearance of acid.
format article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_reports_2319669558</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2319669558</sourcerecordid><originalsourceid>FETCH-proquest_reports_23196695583</originalsourceid><addsrcrecordid>eNpjYeA0MDAx1zU0MY_gYOAqLs4yMDC1NLAw5mRwcfcPcrFS8MwrSy0uyUxPLMnMS1dIzEtRyE3MS0yHcBQy85KLUhOLgbycSoWCotSyxJzUvBKF5Py8lMySzPw8HgbWtMSc4lReKM3NoOTmGuLsoVtQlF9YCjQ4vii1IL-opDjeyNjQ0szM0tTUwpgoRQBdUTmL</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2319669558</pqid></control><display><type>article</type><title>GORD: Investigating and managing an increasingly prevalent condition</title><source>Alma/SFX Local Collection</source><creator>O'Connell, Jim ; Farrell, Richard</creator><creatorcontrib>O'Connell, Jim ; Farrell, Richard</creatorcontrib><description>[...]patients aged 50 years or older or those with alarm symptoms or red flags including unintentional weight loss, anaemia/signs of GI bleeding, dysphagia, odynophagia, family history in first-degree relative of upper GI malignancy, persistent vomiting, and abnormal imaging suggestive of organic disease should be referred for an urgent endoscopy. [...]it often presents with dyspeptic symptoms. In patients with dyspepsia or GORD who have had H. pylori ruled out and are non-responsive to lifestyle modification, it is reasonable to start a trial of acid suppression therapy - a four-week treatment period with high-dose PPI therapy followed by a stepdown to the lowest dose that keeps symptoms under control. Some patients whose symptoms persist despite an adequate trial of high-dose PPI therapy may benefit from the addition of antacids like Gaviscon, fast-acting histamine antagonists like famotidine and prokinetic agents like Motilium to increase oesopha-geal peristalsis and gastric clearance of acid.</description><identifier>ISSN: 0047-147X</identifier><language>eng</language><publisher>Sutton: Irish Medical Times</publisher><subject>Acids ; Alcohol ; Anemia ; Asymptomatic ; Caffeine ; Cancer ; Carcinogens ; Disease ; Dysphagia ; Endoscopy ; Gastroenterology ; Gastroesophageal reflux ; Hernias ; Histamine ; Larynx ; Lifestyles ; Protons ; Quality of life</subject><ispartof>Irish Medical Times, 2019-11, p.4-6</ispartof><rights>Copyright Irish Medical Times Nov 2019</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>312,776,780,787</link.rule.ids></links><search><creatorcontrib>O'Connell, Jim</creatorcontrib><creatorcontrib>Farrell, Richard</creatorcontrib><title>GORD: Investigating and managing an increasingly prevalent condition</title><title>Irish Medical Times</title><description>[...]patients aged 50 years or older or those with alarm symptoms or red flags including unintentional weight loss, anaemia/signs of GI bleeding, dysphagia, odynophagia, family history in first-degree relative of upper GI malignancy, persistent vomiting, and abnormal imaging suggestive of organic disease should be referred for an urgent endoscopy. [...]it often presents with dyspeptic symptoms. In patients with dyspepsia or GORD who have had H. pylori ruled out and are non-responsive to lifestyle modification, it is reasonable to start a trial of acid suppression therapy - a four-week treatment period with high-dose PPI therapy followed by a stepdown to the lowest dose that keeps symptoms under control. Some patients whose symptoms persist despite an adequate trial of high-dose PPI therapy may benefit from the addition of antacids like Gaviscon, fast-acting histamine antagonists like famotidine and prokinetic agents like Motilium to increase oesopha-geal peristalsis and gastric clearance of acid.</description><subject>Acids</subject><subject>Alcohol</subject><subject>Anemia</subject><subject>Asymptomatic</subject><subject>Caffeine</subject><subject>Cancer</subject><subject>Carcinogens</subject><subject>Disease</subject><subject>Dysphagia</subject><subject>Endoscopy</subject><subject>Gastroenterology</subject><subject>Gastroesophageal reflux</subject><subject>Hernias</subject><subject>Histamine</subject><subject>Larynx</subject><subject>Lifestyles</subject><subject>Protons</subject><subject>Quality of life</subject><issn>0047-147X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNpjYeA0MDAx1zU0MY_gYOAqLs4yMDC1NLAw5mRwcfcPcrFS8MwrSy0uyUxPLMnMS1dIzEtRyE3MS0yHcBQy85KLUhOLgbycSoWCotSyxJzUvBKF5Py8lMySzPw8HgbWtMSc4lReKM3NoOTmGuLsoVtQlF9YCjQ4vii1IL-opDjeyNjQ0szM0tTUwpgoRQBdUTmL</recordid><startdate>20191101</startdate><enddate>20191101</enddate><creator>O'Connell, Jim</creator><creator>Farrell, Richard</creator><general>Irish Medical Times</general><scope>0U~</scope><scope>1-H</scope><scope>3V.</scope><scope>7WY</scope><scope>7X7</scope><scope>7XB</scope><scope>883</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8FL</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BEZIV</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FRNLG</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K60</scope><scope>K6~</scope><scope>K9.</scope><scope>L.-</scope><scope>L.0</scope><scope>M0F</scope><scope>M0S</scope><scope>PQBIZ</scope><scope>PQBZA</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope></search><sort><creationdate>20191101</creationdate><title>GORD: Investigating and managing an increasingly prevalent condition</title><author>O'Connell, Jim ; Farrell, Richard</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_reports_23196695583</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Acids</topic><topic>Alcohol</topic><topic>Anemia</topic><topic>Asymptomatic</topic><topic>Caffeine</topic><topic>Cancer</topic><topic>Carcinogens</topic><topic>Disease</topic><topic>Dysphagia</topic><topic>Endoscopy</topic><topic>Gastroenterology</topic><topic>Gastroesophageal reflux</topic><topic>Hernias</topic><topic>Histamine</topic><topic>Larynx</topic><topic>Lifestyles</topic><topic>Protons</topic><topic>Quality of life</topic><toplevel>online_resources</toplevel><creatorcontrib>O'Connell, Jim</creatorcontrib><creatorcontrib>Farrell, Richard</creatorcontrib><collection>Global News &amp; ABI/Inform Professional</collection><collection>Trade PRO</collection><collection>ProQuest Central (Corporate)</collection><collection>ABI/INFORM Collection</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ABI/INFORM Trade &amp; Industry (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ABI/INFORM Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Business Premium Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Business Premium Collection (Alumni)</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Business Collection (Alumni Edition)</collection><collection>ProQuest Business Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ABI/INFORM Professional Advanced</collection><collection>ABI/INFORM Professional Standard</collection><collection>ABI/INFORM Trade &amp; Industry</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>One Business (ProQuest)</collection><collection>ProQuest One Business (Alumni)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><jtitle>Irish Medical Times</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>O'Connell, Jim</au><au>Farrell, Richard</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>GORD: Investigating and managing an increasingly prevalent condition</atitle><jtitle>Irish Medical Times</jtitle><date>2019-11-01</date><risdate>2019</risdate><spage>4</spage><epage>6</epage><pages>4-6</pages><issn>0047-147X</issn><abstract>[...]patients aged 50 years or older or those with alarm symptoms or red flags including unintentional weight loss, anaemia/signs of GI bleeding, dysphagia, odynophagia, family history in first-degree relative of upper GI malignancy, persistent vomiting, and abnormal imaging suggestive of organic disease should be referred for an urgent endoscopy. [...]it often presents with dyspeptic symptoms. In patients with dyspepsia or GORD who have had H. pylori ruled out and are non-responsive to lifestyle modification, it is reasonable to start a trial of acid suppression therapy - a four-week treatment period with high-dose PPI therapy followed by a stepdown to the lowest dose that keeps symptoms under control. Some patients whose symptoms persist despite an adequate trial of high-dose PPI therapy may benefit from the addition of antacids like Gaviscon, fast-acting histamine antagonists like famotidine and prokinetic agents like Motilium to increase oesopha-geal peristalsis and gastric clearance of acid.</abstract><cop>Sutton</cop><pub>Irish Medical Times</pub></addata></record>
fulltext fulltext
identifier ISSN: 0047-147X
ispartof Irish Medical Times, 2019-11, p.4-6
issn 0047-147X
language eng
recordid cdi_proquest_reports_2319669558
source Alma/SFX Local Collection
subjects Acids
Alcohol
Anemia
Asymptomatic
Caffeine
Cancer
Carcinogens
Disease
Dysphagia
Endoscopy
Gastroenterology
Gastroesophageal reflux
Hernias
Histamine
Larynx
Lifestyles
Protons
Quality of life
title GORD: Investigating and managing an increasingly prevalent condition
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T20%3A24%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=GORD:%20Investigating%20and%20managing%20an%20increasingly%20prevalent%20condition&rft.jtitle=Irish%20Medical%20Times&rft.au=O'Connell,%20Jim&rft.date=2019-11-01&rft.spage=4&rft.epage=6&rft.pages=4-6&rft.issn=0047-147X&rft_id=info:doi/&rft_dat=%3Cproquest%3E2319669558%3C/proquest%3E%3Cgrp_id%3Ecdi_FETCH-proquest_reports_23196695583%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2319669558&rft_id=info:pmid/&rfr_iscdi=true